Want to join the conversation?
Biotechnology company $TMO said that it is providing the first test kits in the US for serological detection of the Zika virus in research applications. Made by EUROIMMUN AG, these kits can differentiate between Zika, dengue and chikungunya viruses.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.
$VZ down more than 2% after a disappointing third quarter. A lot of uncertainty on the Yahoo deal too.